Using insect cells, scientists in Vienna have developed an alternative method for producing the H1N1 vaccine. The researchers say the discovery, detailed in the Biotechnology Journal, will aid the fight against influenza pandemics by speeding up production and making it easier to meet the demand for vaccines.
"Recent outbreaks of influenza highlight the importance of a rapid and sufficient vaccine supply for pandemic and inter pandemic strains," said co-author Florian Krammer from the University of Natural Resources and Applied Life Science in Vienna. "However, classical manufacturing methods for vaccines fail to satisfy this demand."
Traditional influenza vaccines, which are produced in embryonated chicken eggs, can be manufactured in the quantities needed for seasonal strains of influenza. Yet because of limited egg supply this method may be insufficient in a pandemic scenario, such as the current H1 N1 'swine flu' pandemic.
The team's new method turns to insect cell based technology to create recombinant influenza virus-like particles (VLPs), which resemble virus particles but lack the viral nucleic acid, so they are not infectious.
The Austrian team took just ten weeks to produce swine-origin pandemic H1N1 influenza VLPs for immunological study in mice. This shows that production of a mock-up vaccine is feasible in this time range, outcompeting conventional production methods which take months.
Using insect cells also bypasses the disadvantages of egg-based production, such as limited production capacity, allergic reactions to egg proteins and biosafety issues.
"Our work demonstrates that recombinant influenza virus-like particles are a very fast, safe and efficient alternative to conventional influenza vaccines and represents a significant new approach for newly emerging influenza strains like swine-origin H1N1 or H5N1" concluded Krammer.
"Virus-like particles will be one solution to tackle the biological variability of influenza pandemics," said journal editor Professor Alois Jungbauer. "Mutated strains can be quickly engineered. So in this respect the teams' work is an extremely valuable contribution to modern vaccine production."
Citation: Florian Krammer, Sabine Nakowitsch, Paul Messner, Dieter Palmberger, Boris Ferko, Reingard Grabherr, 'Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice', Biotechnology Journal Online; doi: 10.1002/biot.200900267
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Religious People View Science Favorably But Reject Some Theories - Just Like Everyone Else
- Spider-Man Webbing: How Many Calories Does It Take To Produce All That Silk?
- Battery Leasing And Better Charging Will Make Electric Cars Popular
- Why Climate Scientists Shouldn't Testify Before Congress
- Easter Island Mystery: What Really Happened To Rapa Nui Society?
- Outsourcing: 3 Ways To Stop Medical Research Brain Drain
- Lepton-Flavor-Violating Higgs Decays Fit In With LHCb Anomalies
- "The first three paragraphs of your article clash with the relatively cogent review of the published..."
- "Seven years is too short. 18+ years of warming hiatus is too short too when it pertains to questioning..."
- "Nothing false about it. They are the only two groups that count, meaning everything else is window..."
- "Hank i stand corrected om the NIH issue and i agree that research should be bases not om politics..."
- "I once heard that the FDA was Milton Friedman's prime example of bureaucracy run amok. He would..."
- Biofouling: Ocean acidification changes make a difference
- Cantona: Long series of droughts doomed Mexican city 1,000 years ago
- Flame retardants linked to preterm birth
- Erratic as normal: Arctic sea ice loss isn't predictable in the short term
- Long-necked 'dragon' named Qijianglong discovered in China